EUVIMEDEUVIMED entdecken
Crossref

Poly( N ‐methyl‐ N ‐vinylacetamide): A Strong Alternative to PEG for Lipid‐Based Nanocarriers Delivering siRNA

Manon Berger iD, François Toussaint, Sanaa Ben Djemaa, Erik Maquoi, Hélène Pendeville, Brigitte Evrard, Christine Jerôme iD, Jeanne Leblond Chain, Anna Lechanteur, Denis Mottet, Antoine Debuigne iD, Géraldine Piel iD

Advanced Healthcare Materials · 2024-03 · 13 (8)

DOI: 10.1002/adhm.202302712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 30.11.2023. Verfasst von Manon Berger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, Avenue Hippocrate 15, Liège, 4000, Belgium. Hauptthemen laut MEDLINE: Liposomes, Polyethylene Glycols, Polyvinyls. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Wallonia-Brussels Federation (grant for Concerted Research Actions, LIPEGALT project, ULiège).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid‐based nanocarriers have demonstrated high interest in delivering genetic material, exemplified by the success of Onpattro and COVID‐19 vaccines. While PEGylation imparts stealth properties, it hampers cellular uptake and endosomal escape, and may trigger adverse reactions like accelerated blood clearance (ABC) and hypersensitivity reactions (HSR). This work highlights the great potential of amphiphilic poly(N‐methyl‐N‐vinylacetamide) (PNMVA) derivatives as alternatives to lipid‐PEG for siRNA delivery. PNMVA compounds with different degrees of polymerization and hydrophobic segments, are synthesized. Among them, DSPE (1,2‐distearoyl‐sn‐glycero‐3‐phosphoethanolamine)‐PNMVA efficiently integrates into lipoplexes and LNP membranes and prevents protein corona formation around these lipid carriers, exhibiting stealth properties comparable to DSPE‐PEG. However, unlike DSPE‐PEG, DSPE‐PNMVA 24 shows no adverse impact on lipoplexes cell uptake and endosomal escape. In in vivo study with mice, DSPE‐PNMVA 24 lipoplexes demonstrate no liver accumulation, indicating good stealth properties, extended circulation time after a second dose, reduced immunological reaction, and no systemic pro‐inflammatory response. Safety of DSPE‐PNMVA 24 is confirmed at the cellular level and in animal models of zebrafish and mice. Overall, DSPE‐PNMVA is an advantageous substitute to DSPE‐PEG for siRNA delivery, offering comparable stealth and toxicity properties while improving efficacy of the lipid‐based carriers by minimizing the dilemma effect and reducing immunological reactions, meaning no ABC or HSR effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesPolyethylene GlycolsPolyvinylsMiceHumansAnimalsCOVID-19 VaccinesZebrafishRNA, Small InterferingPhosphatidylethanolamines

Stichwörter der Autor:innen

PEG alternativelipid nanoparticleslipoplexespoly(N‐methyl‐N‐vinylacetamide)siRNA delivery

Substanzen

LiposomesPolyethylene Glycolspoly(N-methyl-N-vinylacetamide)COVID-19 VaccinesRNA, Small InterferingPhosphatidylethanolaminesPolyvinyls

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, Avenue Hippocrate 15, Liège, 4000, Belgium.
  • Center for Education and Research on Macromolecules CERM, CESAM Research Unit, University of Liège, Allée du Six Août, 13, Liège, 4000, Belgium.
  • Gene Expression and Cancer Laboratory GEC, GIGA-Molecular Biology of Diseases, University of Liège, Avenue de l'Hôpital 11, Liège, 4000, Belgium.
  • Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liège, Avenue Hippocrate, 13, Liège, 4000, Belgium.
  • Platform Zebrafish Facility and Transgenics, GIGA, University of Liège, Avenue de l'Hôpital 11, Liège, 4000, Belgium.
  • University of Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, 146 rue Léo Saignat, Bordeaux, F-33000, France.

ORCID-Profile: Manon Berger, Christine Jerôme, Antoine Debuigne, Géraldine Piel

Förderung

  • Wallonia-Brussels Federation (grant for Concerted Research Actions, LIPEGALT project, ULiège)

Zitieren

APA

Berger, M., Toussaint, F., Ben Djemaa, S., Maquoi, E., Pendeville, H., Evrard, B., Jerôme, C., Leblond Chain, J., Lechanteur, A., Mottet, D., Debuigne, A., & Piel, G. (2024). Poly( N ‐methyl‐ N ‐vinylacetamide): A Strong Alternative to PEG for Lipid‐Based Nanocarriers Delivering siRNA. Advanced Healthcare Materials, 13(8). https://doi.org/10.1002/adhm.202302712

Vancouver

Berger M, Toussaint F, Ben Djemaa S, Maquoi E, Pendeville H, Evrard B, et al. Poly( N ‐methyl‐ N ‐vinylacetamide): A Strong Alternative to PEG for Lipid‐Based Nanocarriers Delivering siRNA. Advanced Healthcare Materials. 2024;13(8). doi:10.1002/adhm.202302712

BibTeX
@article{Berger2024,
  author = {Berger, Manon and Toussaint, François and Ben Djemaa, Sanaa and Maquoi, Erik and Pendeville, Hélène and Evrard, Brigitte and Jerôme, Christine and Leblond Chain, Jeanne and Lechanteur, Anna and Mottet, Denis and Debuigne, Antoine and Piel, Géraldine},
  title = {Poly( N ‐methyl‐ N ‐vinylacetamide): A Strong Alternative to PEG for Lipid‐Based Nanocarriers Delivering siRNA},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {8},
  doi = {10.1002/adhm.202302712}
}
Kostenlos starten →